Diagnostyka S.A.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
7.95 PLN
223.33 M PLN
1.95 B PLN
16.15 M
About Diagnostyka S.A.
Sector
Industry
CEO
Jakub Swadzba
Website
Headquarters
Kraków
Founded
1998
IPO date
Feb 7, 2025
Identifiers
2
ISIN PLDGNST00012
Diagnostyka SA engages in the operation of medical laboratories. It provides diagnostic services for individual clients as well as public and private health care. The company was founded by Jakub Swadzba in 1998 and is headquartered in Krakow, Poland.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
ETFBM40TR
BETA ETF WIG40TR PORTFELOWY FUNDUSZ INWESTYCYJNY ZAMKNIETY AWeight
2.51%
Market value
4.22 M
USD
Explore more ETFs
Frequently Asked Questions
The current price of DIA is 180.40 PLN — it has decreased by −2.34% in the past 24 hours. Watch Diagnostyka S.A. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GPW exchange Diagnostyka S.A. stocks are traded under the ticker DIA.
DIA stock has fallen by −0.14% compared to the previous week, the month change is a −7.61% fall, over the last year Diagnostyka S.A. has showed a 38.77% increase.
We've gathered analysts' opinions on Diagnostyka S.A. future price: according to them, DIA price has a max estimate of 230.00 PLN and a min estimate of 188.00 PLN. Watch DIA chart and read a more detailed Diagnostyka S.A. stock forecast: see what analysts think of Diagnostyka S.A. and suggest that you do with its stocks.
DIA stock is 3.46% volatile and has beta coefficient of 0.47. Track Diagnostyka S.A. stock price on the chart and check out the list of the most volatile stocks — is Diagnostyka S.A. there?
Today Diagnostyka S.A. has the market capitalization of 6.14 B, it has decreased by −1.04% over the last week.
Yes, you can track Diagnostyka S.A. financials in yearly and quarterly reports right on TradingView.
Diagnostyka S.A. is going to release the next earnings report on Apr 23, 2026. Keep track of upcoming events with our Earnings Calendar.
Diagnostyka S.A. revenue for the last quarter amounts to 613.70 M PLN, despite the estimated figure of 603.60 M PLN. In the next quarter, revenue is expected to reach 618.47 M PLN.
DIA net income for the last quarter is 78.06 M PLN, while the quarter before that showed 63.81 M PLN of net income which accounts for 22.33% change. Track more Diagnostyka S.A. financial stats to get the full picture.
Yes, DIA dividends are paid annually. The last dividend per share was 3.31 PLN. As of today, Dividend Yield (TTM)% is 1.82%. Tracking Diagnostyka S.A. dividends might help you take more informed decisions.
As of Feb 14, 2026, the company has 6.97 K employees. See our rating of the largest employees — is Diagnostyka S.A. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Diagnostyka S.A. EBITDA is 567.17 M PLN, and current EBITDA margin is 24.66%. See more stats in Diagnostyka S.A. financial statements.
Like other stocks, DIA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Diagnostyka S.A. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Diagnostyka S.A. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Diagnostyka S.A. stock shows the neutral signal. See more of Diagnostyka S.A. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.